ENTITY
Shanghai Junshi Biosciences

Shanghai Junshi Biosciences (1877 HK)

209
Analysis
Health CareChina
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Refresh
15 Jan 2019 09:06

Last Week in GER IPO Research: Leong Hup, China Tobacco, Futu and Weimob

We slide into 2019 with GER's recap of our latest IPO research. This week, we talk chicken as Arun initiates on the IPO Malaysian poultry producer...

Logo
609 Views
Share
bearishTencent Music
17 Dec 2018 09:01

Last Week’s GER IPO Research: Tencent Music, IPO Trading Strategy Deep Dive, WuXi, Junshi & Xinyi

Another busy week for IPO research from the GER team. This week, we recap the Tencent Music Entertainment (TME US) IPO which we noted is more...

Logo
425 Views
Share
11 Dec 2018 09:33

Junshi Bioscience (君实医药) IPO: Rich Valuation, but Catalyst Ahead

Shanghai Junshi Biosciences, a China-based biotechnology company listed on the NEEQ market (ticker 833330.NEEQ) with a market capitalization of USD...

Logo
802 Views
Share
10 Dec 2018 20:12

Junshi Biosciences IPO Valuation: Sensibly Priced with Upside at the Low-End

Shanghai Junshi Bioscience Co. Ltd. (1387344D CH) launched its Hong Kong IPO today. The mid-point of Junshi's IPO price range of HK$19.38-20.38 per...

Logo
501 Views
Share
bullishTencent Music
08 Dec 2018 18:42

Last Week's GER IPO Research: Tencent Music, Softbank, Weimob, Luzhou, Junshi, Yancoal and Asiainfo

We had another busy week for IPO research the GER team. This week, we recommend participating in the Tencent Music Entertainment (TME US) IPO,...

Logo
491 Views
Share
x